The Valley Desk

NCT03907852 · Interventional trial

Phase 1/2 Trial of Gavo-cel (TC-210) in Patients With Advanced Mesothelin-Expressing Cancer

Overall registry status Active not recruiting

Phase 1 · Phase 2

Conditions Cholangiocarcinoma, Cholangiocarcinoma Recurrent, High Grade Ovarian Serous Adenocarcinoma, Mesothelioma, Mesothelioma Peritoneum, Mesothelioma, Malignant, Mesothelioma; Pleura, Mesotheliomas Pleural, Non Small Cell Lung Cancer, Non Small Cell Lung Cancer Metastatic, Ovarian Cancer

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov